Skip to Content

G 343 (Oxybutynin Chloride Extended Release 15 mg)

Pill with imprint G 343 is White, Round and has been identified as Oxybutynin Chloride Extended Release 15 mg. It is supplied by Teva Pharmaceuticals USA.

Oxybutynin is used in the treatment of urinary incontinence; urinary frequency; dysuria; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 343

Oxybutynin chloride extended release 15 mg G 343
Oxybutynin chloride extended release 15 mg G 343
Oxybutynin chloride extended release 15 mg G 343

Oxybutynin Chloride Extended Release

Imprint
G 343
Strength
15 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-5208
Inactive Ingredients
hypromelloses, lactose monohydrate, methacrylic acid, microcrystalline cellulose, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G 343"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.